D.E. Shaw & Co
CALA

D.E. Shaw & Co’s Calithera Biosciences, Inc CALA Stock Holding History

D.E. Shaw & Co’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,249
Closed -$28K – 5807
2022
Q2 		$28K Sell
11,249
-728
-6% -$3.38K ﹤0.01% 4951
2022
Q1 		$97K Sell
11,977
-63,951
-84% -$653K ﹤0.01% 5003
2021
Q4 		$1.01M Buy
75,928
+73,331
+2,824% +$1.84M ﹤0.01% 3924
2021
Q3 		$113K Sell
2,597
-350
-12% -$15.1K ﹤0.01% 4702
2021
Q2 		$123K Buy
2,947
+1,891
+179% +$83.1K ﹤0.01% 4530
2021
Q1 		$51K Sell
1,056
-1,853
-64% -$108K ﹤0.01% 3963
2020
Q4 		$286K Sell
2,909
-2,156
-43% -$189K ﹤0.01% 3618
2020
Q3 		$349K Buy
5,065
+1,118
+28% +$97.6K ﹤0.01% 3374
2020
Q2 		$417K Buy
3,947
+1,055
+36% +$125K ﹤0.01% 3481
2020
Q1 		$257K Sell
2,892
-2,985
-51% -$356K ﹤0.01% 3545
2019
Q4 		$671K Buy
5,877
+1,376
+31% +$103K ﹤0.01% 3243
2019
Q3 		$279K Buy
+4,501
New +$360K ﹤0.01% 3498
2017
Q4 		– Sell
-2,101
Closed -$662K – 3801
2017
Q3 		$662K Buy
2,101
+29
+1% +$9.15K ﹤0.01% 2751
2017
Q2 		$615K Sell
2,072
-1,534
-43% -$410K ﹤0.01% 2713
2017
Q1 		$833K Sell
3,606
-274
-7% -$47.3K ﹤0.01% 2424
2016
Q4 		$252K Sell
3,880
-201
-5% -$12.6K ﹤0.01% 3184
2016
Q3 		$265K Buy
4,081
+2,219
+119% +$143K ﹤0.01% 3094
2016
Q2 		$138K Buy
1,862
+139
+8% +$13.9K ﹤0.01% 3223
2016
Q1 		$196K Buy
+1,723
New +$195K ﹤0.01% 3196

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co's CALA Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 11,249 shares — an estimated $28K sold.

D.E. Shaw & Co first reported a position in CALA in Q1 2016 and held it in 19 quarters. The position peaked at $1.01M in Q4 2021. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 11,249 Calithera Biosciences, Inc shares in Q3 2022, an estimated $28K.
  • D.E. Shaw & Co first reported a position in Calithera Biosciences, Inc in Q1 2016 and held it in 19 quarters.
  • D.E. Shaw & Co's Calithera Biosciences, Inc position peaked at $1.01M in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.